MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-18-0005665
Supercure Biotech Private Limited
Supercure Biotech Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹42.03 Cr
▲ 6% YoY
Net profit · FY 2024
₹22.3 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹1.07 Cr
EBITDA margin 2.5%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹4.42 Lakh
Issued & subscribed
Open charges
₹5.16 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
10
Provident fund records
About Supercure Biotech Private Limited
Data last updated:
Supercure Biotech Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2013PTC247822. Its GSTIN is 06AASCS7939R1Z1 (Haryana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹4.42 Lakh. It is led by directors Viresh Kumar and Arpit Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No 100 2nd Floor Pu Block Pitampura, Delhi, India – 110088.
As per the financials filed for FY 2024, the company reported a revenue of ₹42.03 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹22.3 Lakh (net margin 0.5%) and EBITDA of ₹1.07 Cr (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 13% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Supercure. As per MCA filings, the company has open charges of ₹5.16 Cr on record. Court records list 25 cases involving the company, including 8 filed by the company and 17 filed against it; 12 cases are pending.
Supercure Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-18-0005665). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100DL2013PTC247822
Registration Number 247822
Incorporation Date 04 February 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-18-0005665
Key People
Viresh Kumar Director Arpit Choudhary Director Recognitions & Rankings of Supercure Biotech
Contact details
Supercure Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No 100 2nd Floor Pu Block Pitampura, Delhi, India – 110088
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Supercure Biotech Private Limited, buy the company report.
Comprehensive company report
Supercure Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Supercure Biotech operates one associated brand: Supercure. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Hosts a digital marketplace for various local services. | supercure.in |
Business activity
The main business activity of Supercure Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Supercure Biotech Private Limited, buy the company report.
Financials of Supercure Biotech Private Limited
FY 2025 filings availableSupercure Biotech Private Limited reported revenue of ₹42.03 Cr (up 6% YoY) for FY 2024.
Revenue · FY 2024
₹42.03 Cr ▲ 6%
Net profit · FY 2024
₹22.3 Lakh margin 0.5%
EBITDA · FY 2024
₹1.07 Cr margin 2.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 12%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 24%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 6% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Supercure Biotech Private Limited, buy the company report.
Board of directors of Supercure Biotech Private Limited
Supercure Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Viresh Kumar Also directs: Anubhavam Cure LLP, Davvero Healthcare LLP | Director | 04 Feb 2013 | 13 Years 8 Months | Current |
| Arpit Choudhary Also directs: Davvero Healthcare LLP | Director | 01 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Supercure Biotech Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brussels Laboratories Pvt Ltd | ₹42.73 Cr (FY 2025) | 7.0% | Dist-Ahmedabad, Gujarat, India | |||
| La Chemico Pvt Ltd | ₹42.52 Cr (FY 2024) | 0.0% | Kolkata, West Bengal, India | |||
| Maya Biotech Private Limited | ₹42.5 Cr (FY 2024) | -3.0% | Chandigarh, India | |||
| Base Medico Private Limited | ₹42.21 Cr (FY 2025) | -12.0% | Vadodara, Gujarat, India | |||
| Spectrum Formulation Private Limited | ₹42.18 Cr (FY 2025) | 23.0% | Indore, Madhya Pradesh, India | |||
| Supercure Biotech Private Limitedthis company | ₹42.03 Cr (FY 2024) | ₹22.3 Lakh | 0.5% | 6.0% | Delhi, India | |
| International Ingredients & Excipients Private Limited | ₹41.96 Cr (FY 2025) | 58.0% | Chennai, Tamil Nadu, India | |||
| Samrudh Pharmacare Private Limited | ₹41.88 Cr (FY 2024) | -7.0% | Mumbai, Maharashtra, India | |||
| Aap Pharma Technologies India Private Limited | ₹41.83 Cr (FY 2024) | -13.0% | Hyderabad, Telangana, India | |||
| Elbrit Life Sciences Private Limited | ₹41.77 Cr (FY 2024) | 39.0% | Erode, Tamil Nadu, India |
To see the full peer comparison of Supercure Biotech Private Limited, buy the company report.
Auditor
Supercure Biotech Private Limited is audited by JSK & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JSK & ASSOCIATES | FY 2021 | 015469N |
Shareholding
The shareholding of Supercure Biotech Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Supercure Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.16 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Aug 2025 | 101147877 | Others | ₹20 Lakh | Open | |
| 22 Nov 2024 | 101012776 | Karnataka Bank Ltd. | ₹30 Lakh | Open | |
| 01 Jan 2024 | 100849811 | Karnataka Bank Ltd. | ₹16.4 Lakh | Open | |
| 28 Oct 2021 | 100496443 | Others | ₹4.25 Cr | Open | |
| 27 Dec 2017 | 100156060 | Karnataka Bank Ltd. | ₹25 Lakh | Open |
To see the full charge records of Supercure Biotech Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Supercure Biotech Private Limited has 25 court cases on record: 8 filed by Supercure Biotech, 17 filed against it. 12 cases are pending and 13 are disposed.
Total cases
25
Filed by the company
8
Filed against the company
17
Pending
12
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 15 | 11 |
| High courts | 3 | 2 | 1 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sonepat, Haryana | Cheque dishonour complaint | Filed by the company against M/S Mridang Pharma Pvt. Ltd. and 1 other | Pending |
| District court, North West, Delhi | Civil suit | Filed against the company by State | Pending |
| District court, Kannauj, Uttar Pradesh | Criminal case | Filed against the company by State Through Dr. Parmesh Kumar Dwivedi | Pending |
| District court, Unnao, Uttar Pradesh | Criminal case | Filed against the company by State | Pending |
| High Court, RAJSTHAN | Writ petition | Filed against the company by Shankar Pharma Distributors and 1 other | Pending |
To see the full case history of Supercure Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supercure Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Supercure Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AASCS7939R1Z1 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Supercure Biotech Private Limited, buy the company report.
Recent activity
Supercure Biotech Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Ravita Chaudhary ceased to be Director on 04 Oct 2021.
AGM
Supercure Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 425.00 Lakh registered on 28 Oct 2021 with Charge ID 100496443 was modified on 22 Aug 2025.
Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 101147877 was registered on 06 Aug 2025.
Filing
Supercure Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 30.00 Lakh with Charge ID 101012776 was registered on 22 Nov 2024.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 16.40 Lakh with Charge ID 100849811 was registered on 01 Jan 2024.
Charges
A charge with Others amounted to Rs. 425.00 Lakh with Charge ID 100496443 was registered on 28 Oct 2021.
Ceased
Ravita Chaudhary ceased to be Director.
Appointed
Arpit Choudhary was appointed as Director.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 25.00 Lakh with Charge ID 100156060 was registered on 27 Dec 2017.
Appointed
Viresh Kumar was appointed as Director.
Incorporation
04 Feb 2013
Supercure Biotech Private Limited was registered on 04 Feb 2013 with Roc Delhi Ii & aged 13 years 8 months as per MCA records.
Frequently asked questions
Supercure Biotech is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2013 (13+ years old) and is registered under CIN U24100DL2013PTC247822.
Supercure Biotech has 2 current directors:
- Viresh Kumar - Director
- Arpit Choudhary - Director
The latest financial statements of Supercure Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Supercure Biotech is 06AASCS7939R1Z1, registered in Haryana.
The CIN (Corporate Identification Number) of Supercure Biotech is U24100DL2013PTC247822. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supercure Biotech has 25 court cases on record: 8 filed by the company and 17 filed against it. 12 are pending. Most are in the district courts.
Supercure Biotech was incorporated on 04 February 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Supercure Biotech by revenue are Brussels Laboratories Pvt Ltd, La Chemico Pvt Ltd, Maya Biotech Private Limited, Base Medico Private Limited, Spectrum Formulation Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ravita Chaudhary ceased to be Director on 04 Oct 2021. Arpit Choudhary was appointed as Director on 01 Oct 2021. Viresh Kumar was appointed as Director on 04 Feb 2013.
Yes, Supercure Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-HR-18-0005665).
The registered office of Supercure Biotech is at H No 100 2nd Floor Pu Block Pitampura, Delhi, India – 110088.